Diskodermolida: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
k Bot: Migrasi 3 pranala interwiki, karena telah disediakan oleh Wikidata pada item d:Q2920456 |
k fixing dead links |
||
Baris 61:
# {{Note|ASCO2004}} ''A phase I pharmacokinetic (PK) trial of XAA296A (Discodermolide) administered every 3 wks to adult patients with advanced solid malignancies.'' 2004 [[American Society of Clinical Oncology|ASCO]] Annual Meeting ([http://www.asco.org/portal/site/ASCO/menuitem.34d60f5624ba07fd506fe310ee37a01d/?vgnextoid=76f8201eb61a7010VgnVCM100000ed730ad1RCRD&vmview=abst_detail_view&confID=26&abstractID=1741 Abstract and Presentation Slides])
# {{Note|AmosProgram}} [http://absmithgroup.chem.upenn.edu/absgroup/currentprojects_discodermolide.asp Amos B. Smith, III Current Research Projects]
# {{Note|Mickel2004}} Mickel, S. J. ''et al.'' ''Org. Process Res. Dev.'' '''2004''', ''8'', [http://pubs.acs.org/journals/oprdfk/8/i01/pdf/op034130e.pdf 92], [http://pubs.acs.org/journals/oprdfk/8/i01/pdf/op0341317.pdf 101], [http://www.webcitation.org/query?id=1184710059794849&url=pubs.acs.org/journals/oprdfk/8/i01/pdf/op034132z.pdf 107], [http://pubs.acs.org/journals/oprdfk/8/i01/pdf/op034133r.pdf 113] and [http://pubs.acs.org/journals/oprdfk/8/i01/pdf/op034134j.pdf 122].
# {{Note|WulffWeb}} [http://poohbah.cem.msu.edu/faculty/wulff/myweb26/Literature_pdf/2004-03-11.pdf Wulff research group] ([[PDF]])
| |||